In this study, we analyzed the expression of CTLA4 mRNA in tumor and blood samples from melanoma patients and found a correlation between decreased tumor and blood CTLA4 and a poorer prognosis in patients with metastatic melanoma. The gene discussed is CTLA4; the disease is neoplasm.